Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New Sjogren's drug CLN-978 enters early human testing

NCT ID NCT07041099

First seen Nov 19, 2025 · Last updated May 23, 2026 · Updated 19 times

Summary

This early-stage study tests a new drug, CLN-978, in 36 adults with active, moderate to severe Sjogren's disease. The main goal is to check safety and side effects. Researchers will also measure how the drug affects immune cells and stays in the body. Participants receive the drug as a shot under the skin.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SJOGREN'S SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cullinan Investigative Site

    RECRUITING

    Orlando, Florida, 32808, United States

  • Cullinan Investigative Site

    RECRUITING

    Memphis, Tennessee, 38103, United States

  • Cullinan Investigative Site

    RECRUITING

    Plano, Texas, 75093, United States

  • Cullinan Investigative Site

    RECRUITING

    Webster, Texas, 77598, United States

  • Cullinan Investigative Site

    RECRUITING

    Salt Lake City, Utah, 84107, United States

  • Cullinan Investigative Site

    RECRUITING

    Brest, 29609, France

  • Cullinan Investigative Site

    RECRUITING

    Le Kremlin-Bicêtre, 94270, France

  • Cullinan Investigative Site

    RECRUITING

    Strasbourg, 67098, France

  • Cullinan Investigative Site

    RECRUITING

    Erlangen, 91054, Germany

  • Cullinan Investigative Site

    RECRUITING

    Hanover, 30625, Germany

  • Cullinan Investigative Site

    RECRUITING

    Roma, 00168, Italy

Conditions

Explore the condition pages connected to this study.